Security Check

Cancer Hospital, Chinese Academy of Medical Sciences

Fudan University China Hospital Rankings: Comprehensive A+++
Top Specialties
Medical Oncology
Ranked #1 nationally; pioneer in gastrointestinal, thoracic, lymphoma, and breast oncology.
Thoracic Surgery
Ranked #1 nationally; earliest department for lung and esophageal cancer diagnosis and surgery.
Radiation Oncology
Pioneered hypofractionated radiotherapy; equipped with advanced proton accelerator and MR-guided Linac.
Hospital Introduction
Founded in 1958 originally as Ritan Hospital, the Cancer Hospital, Chinese Academy of Medical Sciences (CHCAMS) is China's first cancer specialty hospital. It integrates top-tier oncology care, education, and research, serving as the host institution of the National Cancer Center and a globally recognized beacon for malignant tumor treatment.
Class III Grade A
10 National Clinical Key Specialties
National Cancer Center
Guidance-Type National Medical Center
VIP Medical Services Department
Book Consultation
Hospital Tier
Tertiary Grade-A
Ownership
Public Hospital
Location
Beijing, China
Established
1958
Address
No. 17, Panjiayuan South Lane, Chaoyang District, Beijing
Cancer Hospital, Chinese Academy of Medical Sciences
No. 17, Panjiayuan South Lane, Chaoyang District
Beijing, China
1.0 Annual Outpatient Visits (Millions)
65000 Annual Inpatient Discharges
30000 Annual Surgeries
2000 Total Open Beds

Key Insight: CHCAMS handles over 1,000,000 outpatient visits and 30,000+ surgeries annually. Multiple quality indicators — including 5-year survival rate, average length of stay, Grade IV surgery ratio, and Case Mix Index (CMI) — all consistently rank #1 among national oncology specialty hospitals.

Pioneering Care &
Global Oncology Excellence

Cancer Hospital, Chinese Academy of Medical Sciences (CHCAMS) is a Class III Grade A oncology specialty hospital under the National Health Commission, and the first cancer specialty hospital established in the People's Republic of China.

Founded in 1958, the hospital relocated to the Longtan Lake area in 1983, and officially became the host institution of the National Cancer Center (NCC) in 2009. Recognized for unparalleled excellence, it was designated as one of the first batch of "guidance-type" National Medical Centers in 2021.

Host Institution

National Cancer Center (NCC)

National Clinical Research Center for Malignant Tumors
National Tumor Standardized Diagnosis & Treatment QC Center

Fudan University China Hospital Ranking

A+++

2nd Highest Tier Nationally

Consistently ranked #1 nationally in both Oncology and Thoracic Surgery specialty reputation rankings.

Institutional Status & External Evidence

Ranking / External Evaluation
Fudan Comprehensive Ranking A+++
Hospital Classification / Accreditation
Class III Grade A Specialty Hospital National Tertiary Public Hospital Performance #1 (Grade A) RCSEng Recognized Training Base
National Designations / Academic Indicators
NMPA Certified Drug Clinical Research Center National Anti-Tumor Drug Monitoring Network First Batch "Guidance-Type" National Medical Center (2021) National Key Laboratory of Molecular Oncology

National Key Disciplines & Specialties

Medical Oncology

China's first oncology internal medicine department, representing the highest level of cancer medical oncology in China.

Thoracic Surgery

Consistently ranked #1 nationally in the Fudan Rankings. China's earliest department for lung and esophageal cancer.

Head & Neck Surgery

A national key oncology discipline and a recognized training base for British maxillofacial surgeons by the Royal College of Surgeons of England.

Abdominal Surgery

Supported by national funding with multiple international collaborative research projects in colorectal, breast, liver, and pancreatic cancer.

Radiation Oncology

Equipped with China's most advanced radiotherapy technology including a proton accelerator; pioneered hypofractionated radiotherapy.

Diagnostic Imaging & Pathology

Equipped with ultra-high-end spectral CT, 3T high-field functional MRI, and PET-MRI for unparalleled cancer diagnosis.

Medical & Research Innovation Hubs

National Key Laboratory of Molecular Oncology
National Clinical Research Center for Malignant Tumors
National Cancer Center (Host Institution)
National Tumor Standardized Diagnosis & Treatment QC Center
National Drug Clinical Research Center (GCP)
National Anti-Tumor Drug Monitoring Network
First Batch "Guidance-Type" National Medical Center
Beijing Municipal Key Laboratory (1)
Beijing Municipal Key Laboratory (2)
RCSEng Training Base for Maxillofacial Surgeons

Special Medical Services (VIP) & International Care

Cancer Hospital, Chinese Academy of Medical Sciences operates a dedicated Special Medical Services (VIP) Department, thoughtfully designed to serve foreign patients, Hong Kong/Macau/Taiwan residents, and domestic patients requiring premium care capabilities.

  • Specialized VIP clinics covering all major oncology disciplines including head & neck, thoracic, and abdominal surgery.
  • Premium services including priority appointment scheduling and dedicated multidisciplinary team (MDT) consultations.
  • Dedicated pathology consultation center and remote telemedicine aligned with international authoritative guidelines.

Premium Global Standard

As a national-level cancer specialty hospital, CHCAMS actively participates in international academic exchange, with research adopted by NCCN and other international authoritative guidelines, ensuring world-class care standards.

VIP Department Access

Contact via the official APP, website (www.cicams.ac.cn), or phone 010-87788899 to schedule VIP specialty clinic appointments.

Source & Verification

Hospital entity information on this page is maintained from official institutional and government-level sources reviewed by MedBridge. Departmental services, rankings, certifications, and operational information may change over time and should be confirmed with the institution before making a medical decision.

Primary Institutional Source Cancer Hospital, Chinese Academy of Medical Sciences — official hospital website.
Government / Official Records Chinese government and official institutional records reviewed as part of the MedBridge audit process.
MedBridge Verification Hospital entity data has been reviewed against the source records maintained by MedBridge.
QA date: October 6, 2026.